EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Inserm · Sorbonne Université · +35 more institutions
Abstract
To update the European League Against Rheumatism (EULAR) recommendations for the pharmacological treatment of psoriatic arthritis (PsA).
According to the EULAR standardised operating procedures, a systematic literature review was followed by a consensus meeting to develop this update involving 28 international taskforce members in May 2019. Levels of evidence and strengths of recommendations were determined.
Citation impact
- FWCI
- 110.86
- Percentile
- 100%
- References
- 100
Authors
28- LGLaure GossecCorresponding
Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut Pierre Louis d‘Épidémiologie et de Santé Publique
- XBXenofon Baraliakos
Rheumazentrum Ruhrgebiet, Ruhr University Bochum
- AKAndreas Kerschbaumer
Klinik Hietzing, Center for Rheumatology, Medical University of Vienna
- MDMaarten de Wit
European League Against Rheumatism
- IMIain McInnes
University of Glasgow
Topics & keywords
- Medicine
- Psoriatic arthritis
- Intensive care medicine
- Alternative medicine
- Arthritis
- MEDLINE
- Psoriasis
- Dermatology